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Introduction 
Satellite cells can be isolated from skeletal muscle biopsies, activated to proliferating 
myoblast and differentiated into multinuclear myotubes in culture. These cell cultures 
represent an essential model system to intact human skeletal muscle, which can be 
modulated ex vivo. Advantages of this system include; having the most relevant genetic 
background to study human disease (as opposed to rodent cell cultures), the extracellular 
environment can be precisely controlled and the cells are not immortalized, thereby offering 
the possibility of studying innate characteristics of the donor. This review will focus on how 
human myotubes can be used as a tool to study metabolism in skeletal muscles, with a 
special attention to changes in muscle energy metabolism in obesity and type 2 diabetes. 
Limitations of this cell system and possible approaches to improve the current model will 




Characteristics of human myotubes in vitro 
Satellite cells were discovered in 1961 by electron microscopy (Mauro, 1961). The cells can 
be isolated from muscle samples by two principally different mechanisms: by enzymatic 
digestion (Yasin, et al., 1977) or by cell migration (Bonavaud, et al., 2002, Rosenblatt, et al., 
1995). In adult skeletal muscle, satellite cells are in a quiescent state, but are activated in 
response to muscle growth or injury (Blau and Webster, 1981). Proliferation and 
differentiation of human muscle satellite cells can occur in vitro, where they form 
multinucleated myotubes (Blau and Webster, 1981). Over the past 30 years, these cells have 
been extensively used to study glucose and lipid metabolism. The myotubes display 
morphological, metabolic and biochemical similarities to adult skeletal muscle (Gaster, et al., 
2001, Henry, et al., 1995, Thompson, et al., 1996), and thus offer a unique and powerful 
model to distinguish between genetic and environmental factors for instance in the etiology 
of insulin resistance. Examples of protocols for maintaining muscle cells in culture are given 
by Gaster et al. (Gaster, et al., 2001) and Henry et al. (Henry, et al., 1995). 
Activated proliferating satellite cells, also denoted as myoblasts, express myogenic markers 
including MyoD (Hawke and Garry, 2001). After further proliferation, myoblasts either fuse 
with existing muscle fibers or fuse with other myoblasts and form multinucleated myotubes 
(Schultz and McCormick, 1994, Zammit, et al., 2006). The expression of key proteins for both 
glucose (Al-Khalili, et al., 2003) and lipid metabolism (Muoio, et al., 2002) increase during 
differentiation of myoblasts into myotubes. Compared to myoblasts, the protein expression 
pattern of myotubes exhibits a better resemblance to adult skeletal muscle, and myotubes 
are therefore preferred for experimental use (Berggren, et al., 2007). 
Primary human myotubes are generally characterized by low mitochondrial oxidative 
capacity, and their fuel preference is for carbohydrates over lipids (Aas, et al., 2011). This 
may be due to predominant production of ATP by aerobic glycolysis rather than 
mitochondrial oxidative phosphorylation (OXPHOS) (Warburg effect) (Benard, et al., 2010), 
and is likely the result from a lack of proliferation of mitochondria and OXPHOS-activation in 
the absence of appropriate environmental signals in vitro. The cells are normally grown in 




In addition to satellite cells, other progenitor cells also have a myogenic potential, such as 
pericyte-derived cells that can differentiate into myotubes in vitro (Dellavalle, et al., 2007). 
These myotube cultures differ from satellite cell cultures, and less is known about the 
metabolic characteristics of pericyte-derived myotubes.   
 
Glucose and lipid metabolism  
In addition to the glucose transporters GLUT1 and GLUT4, other hexose transporters as 
GLUT3, GLUT5 and GLUT12 are present in skeletal muscles (Stuart, et al., 2006). GLUT1 is 
thought to be involved mainly in basal glucose transport in both rodent (Hansen, et al., 
1998) and human (Ciaraldi, et al., 2005)  skeletal  muscle. In response to insulin stimulation, 
GLUT4, but not GLUT1, is translocated to the cell surface of the skeletal muscle cells, 
resulting in an increase in glucose uptake (Ploug and Ralston, 1998).  However, the ratio of 
GLUT1:GLUT4 is higher in human myotubes compared to adult skeletal muscle (Sarabia, et 
al., 1992), resulting in a lower insulin responsiveness of glucose transport (Al-Khalili, et al., 
2003, Sarabia, et al., 1992). Insulin typically increases glucose uptake by 40-50 % in 
myotubes (Aas, et al., 2002, Al-Khalili, et al., 2003, McIntyre, et al., 2004, Montell, et al., 
2001). Even though the effect of insulin is lower in myotubes than in intact skeletal muscle, 
the responsible molecular mechanisms of glucose transport remain the same (Al-Khalili, et 
al., 2003). Due to a decreased insulin responsiveness of human myotubes, insulin 
concentrations in the range of 0.1 – 1 µM are often applied in studies of human myotubes 
(Aas, et al., 2004, Aguer, et al., 2011, Al-Khalili, et al., 2003, Bell, et al., 2010, Gaster, et al., 
2004, Jackson, et al., 2000, Rune, et al., 2009a). This insulin concentration is markedly above 
the physiological concentration in the picomolar range. Insulin stimulation increases 
glycogen synthesis about 2-fold in human myotubes, which is similar to in vivo observations 
(Aas, et al., 2004, Al-Khalili, et al., 2003, Al-Khalili, et al., 2005). In intact muscle, glycogen 
content is linked to glucose uptake, and reduced glycogen content increases glucose uptake 
(Jensen, et al., 1997). Importantly, low glycogen content also increases insulin-stimulated 
glucose uptake (Jensen, et al., 1997), and reduced glycogen content after exercise is a major 
reason for the improved insulin sensitivity observed after exercise (Jensen, et al., 2011). In 
intact muscles, glycogen content also regulates glucose metabolism, and muscles with high 
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glycogen content have reduced glycogen synthesis during insulin stimulation and channel 
more glucose into glycolysis (Jensen, et al., 2006). In myotubes, we did not observe 
increased glycogen content after incubation with high glucose although basal and insulin-
stimulated glucose uptake decreased (Aas, et al., 2004). Although, the relationship between 
glycogen and glucose uptake has not yet been clearly established, cultured human muscle 
satellite cells may provide a suitable model for the study of glucose metabolism, both in the 
basal and insulin-stimulated state. 
The capacity for long-chain fatty acid oxidation has been compared between homogenates 
of donor muscle biopsies and the derived skeletal muscle cell cultures (Jacobs, et al., 1987, 
Zuurveld, et al., 1985). The palmitate oxidation rate (Jacobs, et al., 1987, Zuurveld, et al., 
1985) and the activity of citrate synthase (Jacobs, et al., 1987) were comparable between 
human myotubes and that measured in homogenates of the donor muscle (m. quadriceps). 
Based on their findings they concluded that cultured human muscle cells represent a 
suitable model for studies on mitochondrial oxidative metabolism of muscle. 
 
Muscle contraction 
Mature myotubes are quiescent and do not typically contract spontaneously. Muscle 
contraction stimulates translocation of GLUT4 and increases glucose uptake (Rose, et al., 
2009). The mechanism for contraction-stimulated glucose uptake in myotube is not clear, 
but contraction activates AMP-activated protein kinase (AMPK), and AMPK activation 
stimulates glucose uptake. However, studies with AMPK knockdown mice showed that 
contraction could stimulate glucose uptake even in muscles where AMPK was kinase-dead 
(Maarbjerg, et al., 2009). Ca2+/calmodulin dependent kinase also seems to be involved in 
contraction-stimulated glucose uptake, and a link between muscle glycogen content and 
contraction-stimulated glucose uptake has been suggested (Aslesen, et al., 2001). Recently, 
it has been shown that human myotubes respond to “exercise”, induced by electrical pulse 
stimulation, in a similar way as to exercising muscle in vivo (Lambernd, et al., 2012, Nikolic, 
et al., 2012a), and this model may be very important to clarify the mechanisms for 
contraction-stimulated glucose uptake. Chronic low-frequency stimulation (CLF) increases 
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glucose uptake and oxidation, oleic acid oxidation, mitochondrial content, AMPK activation, 
and interleukin-6 (IL-6) production (Lambernd, et al., 2012, Nikolic, et al., 2012a).  In fact, 
insulin resistance induced by adipocyte-conditioned media, chemerin and monocyte 
chemotactic protein-1 (MCP-1) was abrogated by electrical pulse stimulation (Lambernd, et 
al., 2012). All together, these observations imply that glucose metabolism, insulin signaling 
and responses to exercise are very similar in human myotubes as in skeletal muscle in vivo.  
 
Fiber type comparison  
Human muscle fibers express three isoforms of myosin heavy chain (MyHC): MyHC-β, MyHC-
2A, and MyHC-2X (respective genes MYH7, MYH2, and MYH1) (Schiaffino and Reggiani, 
2011). The fourth isoform MHC-2B (MYH4) is not detected in humans. The expression of the 
MyHC isoforms is associated with muscle fiber phenotype. The muscle fibers that express 
MyHC-β are characterized as slow, fatigue resistant and oxidative (type 1 muscle fibers), 
whereas the fibers that express MyHC-2A are fast oxidative (type 2A muscle fibers), and the 
MyHC-2X fibers are fast glycolytic (type 2X muscle fibers). Most human muscles consist of all 
three muscle fiber types in varying degrees, depending on the functional demands of the 
muscle (Harridge, et al., 1996), age and gender (Schiaffino and Reggiani, 2011). Studies 
performed in rodents have demonstrated that MyHC isoforms expressed in differentiated 
myotubes were identical to the MyHC expression pattern in the muscle fibers from which 
the satellite cells were isolated (Dusterhoft and Pette, 1993, Rosenblatt, et al., 1996).  In 
human muscle cell cultures it has been found that all myotubes in 8-day differentiated cell 
cultures were immunoreactive for fast MyHC, regardless of donor muscles having mixed 
MyHC expression in vivo (Gaster, et al., 2001) . In our hands, myotube cultures stained at day 
8 after differentiation contained a noteworthy amount of slow muscle fibers as well (Fig. 1), 
and the cell content of MyHC-β proteins increased after chronic electrical pulse stimulation 
of the cells, showing plasticity potential (Nikolic, et al., 2012a).  When satellite cells were 
isolated from pools of single human skeletal muscle fibers exclusively expressing either fast 
or slow MyHC isoform the isolated cells differentiated into myotubes that co-expressed both 
fast and slow MyHC isoforms (Bonavaud, et al., 2001).  In addition to the fast and slow MyHC 
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isoforms present in adult skeletal muscle in vivo, several  developmental  MyHC  isoforms  
are  expressed  in  myotubes  (Bonavaud, et al., 2001). 
Despite the fact that myotubes can be of different types, it has been a question of heated 
debate whether muscle satellite cells are of multiple origin or not, and conflicting results 
have been reported in the literature depending on the markers used to identify cell type 
differences, the species used to obtain cells and the culturing conditions (for review (Schultz 
and McCormick, 1994)). Satellite cells may be heterogenous, and it is not known if there are 
distinct populations of fast twitch (type 2) and slow twitch (type 1) cells. However, when 
grown in culture, human satellite cells mature to myotubes that express MYH1, MYH2, and 
MYH7 (Nikolic, et al., 2012a). In accordance with our observations in human myotubes, 
murine satellite cells isolated from different muscles were uniform regardless of muscle 
origin, and the dominant muscle fiber type both in primary murine myoblast and in the 
murine muscle cell lines was the intermediate MyHC-2A (LaFramboise, et al., 2003). It has 
been suggested that MyHC-2X is the default form of the protein in human skeletal muscle 
(Harridge, 2007). An important additional observation is that the expression pattern of 
MyHC seems to be the same in myotubes from male and female donors (Bonavaud, et al., 
2001). Taken together these findings demonstrate that myotubes differ from donor muscle 
with respect to MyHC expression. 
 
Retention of metabolic characteristics of the muscle cell donor 
Even though cultured human skeletal muscle cells differ from their donor in MyHC 
expression, some metabolic properties of the donor muscle were maintained in the derived 
cell cultures. Several studies have shown that the diabetic phenotype is conserved in 
myotubes established from type 2 diabetic (T2D) subjects (Gaster, et al., 2002, Henry, et al., 
1996, Thompson, et al., 1996), and several potential intrinsic deficiencies in myotubes from 
individuals with T2D have been reported (Gaster, et al., 2002, Gaster, et al., 2004, Henry, et 
al., 1995, Thompson, et al., 1996). For instance, it has been observed primary defects in 
glucose metabolism such as decreased glucose transport and glycogen synthase activity in 
myotubes from diabetic individuals (Gaster, et al., 2002, Henry, et al., 1995, Henry, et al., 
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1996, McIntyre, et al., 2004), decreased insulin-stimulated citrate synthase activities 
(Ortenblad, et al., 2005) and impaired glucose oxidation (Wensaas, et al., 2009). With 
respect to lipid metabolism, decreases in both complete palmitate oxidation and fatty acid 
beta-oxidation have been observed in myotubes from individuals with T2D when compared 
to control cells from obese individuals who were normoglycemic (Cha, et al., 2005, Gaster, et 
al., 2004, Wensaas, et al., 2009). It has also been demonstrated that there is an increased 
formation of fatty acid beta-oxidation products in diabetic cells when chronically exposed to 
fatty acids (Wensaas, et al., 2009), and a reduced tricarboxylic acid (TCA) cycle flux when 
compared to myotubes established from obese subjects (Gaster, 2009). Additionally, 
myotubes from individuals with T2D show increased lipogenesis and lipid accumulation 
when chronically treated with a liver X receptor (LXR) agonist (Kase, et al., 2005) or in the 
presence of the polyunsaturated fatty acid eicosapentaenoic acid (Wensaas, et al., 2009) 
when compared to lean and/or obese control cells. It should be noted that the metabolic 
differences between myotubes from lean donors and myotubes from obese T2D donors are 
very striking, but metabolic differences in myotubes from obese donors and myotubes from 
obese T2D donors are not always as obvious (Gaster, 2007a).  
In myotubes established from young healthy subjects, the capacity to increase lipid oxidation 
in response to increased fatty acid availability in vitro (adaptability) was positively related to 
insulin sensitivity in vivo (Ukropcova, et al., 2005). In a recent study, we observed that 
intracellular lipid oxidation and adaptability were reduced in myotubes established from T2D 
individuals (Corpeleijn, et al., 2010). The variation in intracellular lipid oxidation in vitro was 
significantly related to the in vivo fasting respiratory quotient of the subjects (Corpeleijn, et 
al., 2010). This suggests that skeletal muscle fatty acid handling is intrinsically impaired in 
T2D individuals (Gaster, et al., 2004, Wensaas, et al., 2009). 
Metabolic switching, representing dynamic changes in fatty acid oxidation in skeletal muscle 
cells, is also correlated with clinical phenotypes of cell donors. Myotubes retain the 
characteristics of the donor, which indicates that metabolic switching is an intrinsic 
characteristic of skeletal muscle (Gaster, 2007b, Ukropcova, et al., 2005). This suggests that 
defects in metabolic switching might be one of the primary events in the development of 
obesity and insulin resistance. We have also found that lipid content in myotubes was 
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strongly associated with in vivo maximal oxidative capacity, insulin sensitivity, physical 
activity level and the proportion of type 1 muscle fibers (Bajpeyi, S., unpublished data).  
Insulin-stimulated activation of Akt (PKB) is impaired in skeletal muscle of T2D individuals in 
vivo (Krook, et al., 1998). This defect seems to be maintained in cultures as well (Cozzone, et 
al., 2008). However, insulin-stimulated phosphorylation of Akt is not reduced in muscles 
from 72 h fasted subjects although severe insulin resistance occurs (Vendelbo, et al., 2012). 
Other components in the insulin-signaling cascade, such as activation of Akt substrate of 160 
kDa (AS160), are also impaired in muscles from type 2 diabetic subjects (Karlsson, et al., 
2005). Interestingly, AS160 phosphorylation was also reduced after 72 h fasting, and AS160 
may be a better intracellular signaling molecule reflecting insulin-stimulated glucose uptake 
(Vendelbo, et al., 2012). After inducing insulin resistance by palmitic acid in myotubes, 
phosphorylation of AS160, as well as other signaling proteins, was correspondingly reduced 
(Bikman, et al., 2010). These are only a few examples of reported signaling defects in 
myotubes from obese and insulin resistant subject showing that results from myotubes 
reflect the in vivo situation. 
Gender is definitely a factor affecting energy metabolism in vivo, however, this difference 
does not seem to be maintained in myotube cultures (Rune, et al., 2009b, Salehzadeh, et al., 
2011). Both glucose and palmitic acid metabolism were similar in myotubes from male and 
female donors. Gene (mRNA) expression of several genes involved in glucose and lipid 
metabolism was observed to be higher in skeletal muscle biopsies from female vs male 
donors, but the expression was similar in cultured myotubes from the same donors (Rune, et 
al., 2009b, Salehzadeh, et al., 2011).  
These observations suggest that the characteristics of the in vivo phenotype are to a certain 
extent carried over to the myotubes in vitro. Exactly how myotubes are able to retain the in 
vivo characteristics is not known, however a combination of genetic and epigenetic 
mechanisms are probably involved. Epigenetic regulation of skeletal muscle stem cells and 
skeletal muscle differentiation are well known (see e.g. (Bharathy, et al., 2012, Sousa-Victor, 
et al., 2011)). Exercise (Barres, et al., 2012, Nitert, et al., 2012), diet (Jacobsen, et al., 2012) 
and family history of type 2 diabetes (Nitert, et al., 2012) are all described to influence DNA 
methylation in human skeletal muscle, traits that may follow the isolated satellite cells into 
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cultured myotubes. Thus, acute exercise was found to induce hypomethylation of promoters 
of several metabolic genes (Barres, et al., 2012), and a 6-month exercise intervention 
induced decreased methylation of genes involved in e.g. retinol metabolism, calcium-
signaling pathway, starch and sucrose metabolism, and the insulin-signaling pathway (Nitert, 
et al., 2012). Short-term (5 days) high-fat overfeeding introduced widespread DNA-
methylation changes, changes that were only partly reversed after 6-8 weeks (Jacobsen, et 
al., 2012). 
Mutations are of course carried over from the in vivo to the in vitro situation. One example is 
the naturally occurring R225W mutation in the skeletal muscle-specific γ3 subunit of the 
cellular energy sensor AMPK. This mutation, identified in humans in 2007 (Costford, et al., 
2007), was shown to result in increased muscle glycogen and decreased intramuscular 
triacylglycerol in R225W carriers and was linked to increased AMPK activity in R225W 
cultured myotubes. Further studies have shown that the fuel storage phenotype is 
maintained in the R225W myotubes, and that R225W myotubes also have increased 
mitochondrial content, oxidative capacity and glucose uptake; the latter of which is 
consistent with the fact that R225W carriers show a trend for increased skeletal muscle 
glucose uptake in vivo, as measured by [18F]-fluorodeoxyglucose positron emission 
tomography (Crawford, et al., 2010). The maintenance of the R225W carrier phenotype in 
R225W myotubes is another example of the donor-myotube similarities, which make 
primary human myotube culture systems an extremely useful tool for metabolic research. 
 
Limitations of the myotube model   
Cultured myotubes lack of course the in vivo microenvironment and the communication with 
other cells through direct contact and bioactive substances. Indeed, co-cultures with 
adipocytes may overcome some of these limitations (Trayhurn, et al., 2011). It is also 
important to take notice of that glucose uptake in vivo is regulated by delivery, transport and 
metabolism (Rose and Richter, 2005), whereas cultured myotubes only allow studies of 
transport and metabolism. In these studies, another limitation to the myotube model is that 
compared to in vivo, the insulin-stimulated glucose uptake in primary human myotubes is 
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relatively low (about 1.5-fold increased) (Aas, et al., 2004, Al-Khalili, et al., 2003, McIntyre, et 
al., 2004, Montell, et al., 2001), possibly caused by a low expression of the insulin-responsive 
glucose transporter GLUT4 (Al-Khalili, et al., 2003, Sarabia, et al., 1992). In vivo, GLUT4 is 
more expressed in type 1 oxidative muscle fibers than type 2 fibers (Daugaard, et al., 2000, 
Gaster, et al., 2000, Stuart, et al., 2006), and insulin sensitivity correlates with the proportion 
of slow twitch oxidative fibers in the muscle (Lillioja, et al., 1987). Insulin-stimulated glucose 
uptake is generally greater in slow twitch-enriched muscles than fast-twitch muscles (Zierath 
and Hawley, 2004). For example, white gastrocnemius in rat containing mostly type 2 fibers 
shows a 7-fold response to insulin, whereas glucose uptake increased 11-fold in red 
gastrocnemius (James, et al., 1985). Therefore ways to change the phenotype to a more 
oxidative one would improve the insulin sensitivity. It is also important to note that 
denervation of skeletal muscles reduces GLUT4 expression and causes insulin resistance 
(Jensen, et al., 2009). Indeed, innervation of human myotubes is possible in vitro by co-
culturing with rat motor neurons, and such innervation increases GLUT4 expression 
(Chowdhury, et al., 2005). However, more convenient methodologies are required.   
There are also clear differences in gene expression between muscle biopsies and myotubes. 
A direct comparison of mRNA expression between skeletal muscle biopsy and cultures from 
human myotube show that most genes we studied were expressed higher in biopsies than in 
cells (Fig. 2). The only exception was the lipid droplet protein PLIN3. This could imply less 
active cells, possibly not completely matured to muscle fibers or simply an indication of 
more quiescent cells. Indeed, muscles strips from human adult differentiated muscles can be 
used to study glucose uptake and GLUT4 translocation in vitro (Lund, et al., 1997). This 
methodology has provided important information, but the muscle strips also have their 
limitations. It is not possible to manipulate gene transcription and the strips have limited 
viability.   
Adult stem cells are known to have a finite replication potential. Human myotubes from 
myoblast cultures undergoing senescence exhibit defects in glucose and lipid metabolism 
(Nehlin, et al., 2011). In that study muscle biopsy-derived human satellite cells were grown 
at different passages and differentiated to human myotubes in culture to analyze the 
functional state of various carbohydrate and lipid metabolic pathways. A number of cellular 
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functions were altered as the proliferative potential of myoblasts decreased with increasing 
passage number. The capacity of myoblasts to fuse and differentiate into myotubes was 
reduced, and metabolic processes in myotubes such as glucose uptake, glycogen synthesis, 
glucose oxidation and fatty acid β-oxidation became gradually impaired. Late-passage, non-
proliferating myoblasts cultures showed strong senescence-associated β-galactosidase 
activity, indicating that the observed metabolic defects accompany the induction of a 
senescent state (Nehlin, et al., 2011). 
 
Strategies to improve the human myotube model 
Several parameters of the cell culture model can be improved using different approaches, 
and we have in this review focused on some ways of improving oxidative capacity (Fig. 3). 
The muscle phenotype can be changed; it has been long known that muscle contractile 
activity impacts the muscle phenotype, and that the phenotype can change when the motor 
nerve activity is altered (Vrbova, 1963). In humans, the muscle fiber type composition varies 
among individuals depending on age, gender, genetic background, and activity level. The 
gastrocnemius of sprint athletes, for instance, is dominated by fast twitch type 2 fibers and 
that of top endurance athletes by slow twitch type 1 fibers (Costill, et al., 1976). The 
transition from slow to fast twitch muscle fiber occurs after denervation and by disuse of the 
muscles, such as after spinal cord injury (Andersen, et al., 1996). Increasing age has also 
been associated with an increased proportion of fast fibers (D'Antona, et al., 2003). 
However, this is controversial, since loss of type 2 fibers with age has also been shown 
(Lexell, 1995), as well as changes in biochemical parameters without changes in fiber type 
composition (He, et al., 2001). Type 2 diabetes is also associated with an increased 
proportion of fast, glycolytic type 2 fibers (Marin, et al., 1994, Oberbach, et al., 2006). The 
transition from fast to slow fiber is more difficult to achieve in humans than the other way 
round. The experimental model of chronic low-frequency stimulation (CLF) in animals has 
shown such transitions in rabbits and rats (for review see (Pette and Vrbova, 1999)). The 
plasticity of skeletal muscle in general has been thoroughly reviewed by others (Fluck and 
Hoppeler, 2003, Gundersen, 2010, Schiaffino and Reggiani, 2011).  
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Since myotubes in culture seem to be rather glycolytic, strategies to improve oxidative 
capacity, i.e. induce fiber type switching from fast type 2 to slow type 1 fibers would improve 
the model. The mechanisms involved in fiber type switching are not known in detail, but it is 
clear that gene expression must be changed in some way. Prolonged increase in intracellular 
calcium, activation of the calcineurin pathway and dephosphorylation of the transcription 
factor nuclear factor of activated T-cells (NFAT) has been shown to initiate the slow fiber 
type program (Chin, et al., 1998). Slow fiber type genes were also shown to be upregulated 
by the extracellular signal-regulated kinases (ERK) pathway in rats (Murgia, et al., 2000) and 
by peroxisome-proliferator-activated receptor-gamma co-activator-1 alpha (PGC-1α) in mice 
(Lin, et al., 2002). PGC-1β, on the other hand, is involved in fast twitch (type 2X) fiber 
transition (Arany, et al., 2007). In human skeletal muscle in vivo there seems to be a 
correlation between the expression of the peroxisome proliferator-activated receptors 
(PPAR) α and δ and proportion of type 1 fibers (Kramer, et al., 2006, Russell, et al., 2003). 
Overexpression of a constitutive active PPARδ in adult rat muscles induced slow muscle 
properties (Lunde, et al., 2007). PGC-1α overexpression in primary human myotubes 
promoted an increased lipid oxidative capacity, increased the expression of genes involved 
in regulation of mitochondrial function and biogenesis, and decreased the expression of a 
fast fiber type gene marker (MyHC-2A) when compared to cells infected with an empty 
retrovirus-vector (Nikolic, et al., 2012b). We also observed that PGC-1α overexpression 
increased expression of several genes which were markedly down-regulated during the 
process of cell isolation and culturing when compared to skeletal muscle in vivo. After 
treatment of PGC-1α transfected cells with the selective PPARδ agonist GW501516, 
palmitate oxidation was further increased. GW501516 also increased mRNA levels for 
carnitine palmitoyltransferase-1 (CPT-1). Additionally, a dose-dependent increase in oleate 
oxidation to CO2 was observed in myotubes pretreated for three days with this compound 
during differentiation of the cells (Wensaas, et al., 2007). The PPARδ agonist was also shown 
to increase basal and insulin-mediated glucose transport and lead to phosphorylation of 
AMPK and p38 mitogen-activated protein kinase (MAPK) in cultured human myotubes 
(Kramer, et al., 2007). 
We have recently shown that chronic low-frequency electrical pulse stimulation of human 
myotubes increases glucose and fatty acid oxidation and mitochondrial content (Nikolic, et 
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al., 2012a). Protein content of MyHC-β increased, indicating a fiber type switch. Another 
recent study by Lambernd et al. showed that insulin stimulated glucose uptake was 
increased and insulin resistance could be prevented by chronic electrical pulse stimulation 
(Lambernd, et al., 2012).  In murine C2C12 cells exposed to electrical pulse stimulation (40 
V/60 mm, 24 ms, 1 Hz), there was a decrease in type 2 fibers and an increase in type 1 fibers. 
In addition, ERK1/2, ERK5 and c-Jun N-terminal kinase (JNK) were activated and glucose 
uptake was improved (Nedachi, et al., 2008). GLUT4 mRNA expression was unaltered, but 
GLUT4 recycling was increased, both under basal and insulin-stimulated conditions (Nedachi, 
et al., 2008). In animal studies, elevation in PGC-1α is associated with fiber-type switch from 
glycolytic, fast-twitch type 2B/2X to oxidative, slow-twitch type 2A and 1 muscle fibers 
(Handschin, et al., 2007, Lin, et al., 2002). Expression of PGC-1α was also increased in 
primary rat skeletal muscle cells after electric stimulation for 90 min a day for 5 days 
(Silveira, et al., 2006), as well as in C2C12 cells stimulated for 90 min a day for 4 days or after 
CLF for 24 h (Burch, et al., 2010). In this latter study, expression of several genes involved in 
oxidative phosphorylation, glucose and fatty acid metabolism increased concomitantly, 
although not followed by a clear fiber type switch since both MyHC-β and MyHC-2X 
increased (Burch, et al., 2010). All these studies indicate that oxidative capacity can be 
improved by electrical pulse stimulation (exercise mimetic) of the myotubes.  
It has also been shown in adult rat muscle that PPARδ expression is influenced by muscle 
contractile activity and induces slow muscle fiber properties after somatic gene transfer 
(Lunde, et al., 2007). Thus, strategies to enhance PPARδ activity, by either agonist treatment 
or by gene transfer (not yet shown in human myotubes), may increase the oxidative 
potential of myotubes and promote fiber type switching. However, also other PPARs may be 
targets for increased oxidative capacity. Muoio et al. demonstrated that PPARα protein 
expression was induced during myocyte differentiation (Muoio, et al., 2002), and that its 
activation stimulated lipid oxidation (Djouadi, et al., 2005, Muoio, et al., 2002) and 
decreased triacylglycerol accumulation (Muoio, et al., 2002) in primary human myotubes. 
Treatment with the PPARγ agonist troglitazone reversed impaired fatty acid metabolism in 
skeletal muscle cells from individuals with T2D (Cha, et al., 2005), whereas all the 
thiazolidinediones (troglitazone, rosiglitazone and pioglitazone) normalized the impaired 
fatty acid uptake (Wilmsen, et al., 2003). 
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Other pharmacological approaches, such as treatment of differentiated myotubes with the 
pan-PPAR agonist tetradecylthioacetic acid (TTA) improved complete palmitate oxidation in 
diabetic myotubes, opposed increased lipid accumulation and increased glucose oxidation 
(Wensaas, et al., 2009). The activation of cAMP/PKA and calcium signaling pathways is 
known to promote mitochondrial biogenesis and increase lipid oxidation capacity in vivo 
(Baar, et al., 2002, Hood, 2001). We hypothesized that activation of these signaling pathways 
in human primary myotubes would induce functional changes in lipid and glucose 
metabolism. Activation of cAMP/PKA and calcium signaling pathways by PFI-treatment 
(palmitic acid, forskolin and ionomycin) increased lipid oxidation, storage and lipolysis, as 
well as improved insulin responsiveness in human primary myotubes (Sparks, et al., 2011). 
Activation of LXR in myotubes by an LXR agonist (T0901317) increased glucose uptake and 
oxidation, but promoted also lipogenesis and increased lipid storage (Kase, et al., 2007, Kase, 
et al., 2005). This was further enhanced in myotubes established from T2D donors. However, 
the increased lipid storage in T2D myotubes did not impair insulin-stimulated glucose 
metabolism during the four-day treatment of the cells with an LXR agonist (Kase, et al., 2007, 
Kase, et al., 2005). A new strategy is to grow the myoblasts in nutrient limited culturing 
media to increase the pressure for metabolic remodeling. The OXPHOS vs. glycolytic capacity 
will possibly be changed to increase the ATP yield (Vander Heiden, et al., 2009). It is well 
known that cancer cells in particular, but also other cells, become highly glycolytic when 
grown in high glucose concentrations. Glucose inhibits oxidative phosphorylation, a 
phenomenon known as the Crabtree effect (Diaz-Ruiz, et al., 2011, Ibsen, 1961). This effect 
can possibly be avoided by growing cells in media with other nutrients, such as amino acids, 
lipids or lactate. A problem with this approach is that proliferating cells deficient in ATP will 
undergo apoptosis or cell cycle arrest. However, replacing glucose with galactose during 
differentiation of myoblasts to myotubes did increase the basal mitochondrial oxygen 
consumption rate (Aguer, et al., 2011). Mitochondrial biogenesis was not increased, but 
some mitochondrial enzymes were increased, as well as the AMPK activity (Aguer, et al., 
2011). We have recently confirmed increased oxidative capacity in myotubes grown and 
differentiated in galactose-containing media, assessed as increased oxidation of glucose and 
oleic acid (Kase, et al., 2013). We also showed that suppression of oleic acid oxidation by 
glucose was improved. Preliminary data indicate that removal of glucose (no glucose DMEM 
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with 10 % FCS) and replacement of glucose with lactate (5 mM) could have similar effects on 
oxidative capacity (unpublished observations). 
Like AMPK, the sirtuins (e.g. silent mating type information regulation 2 homologue 1, SIRT1) 
are also regarded as fuel-sensing enzymes. AMPK and SIRT1 have a long-standing 
partnership where they can regulate each other (Ruderman, et al., 2010). Although the 
effect is less than the effect from PPARδ activation, treatment of human myotubes for 4 
days with the AMPK-activator 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide 
(AICAR) or the SIRT-activator SRT1720 led to about 60 % increased oleic acid oxidation (Fig. 
4).  
The antidiabetic drug metformin, which is an activator of AMPK, has been shown to increase 
glucose uptake (Sarabia, et al., 1992) as well as insulin-stimulated glycogen synthesis in 
human myotubes (Al-Khalili, et al., 2005). However, any stimulatory effect of metformin on 
oxidative capacity has, to our knowledge, not been shown. Neither have we been able to 
increase substrate oxidation by metformin (10-100 nM for 4-8 days). Glucose uptake 
increased significantly by about 25 % (± 3) and oleic acid uptake by 19 % (± 3), whereas 
oxidation of the same substrates did not increase equally (unpublished data). 
In vitro, muscle cells fuse to multinucleated fibers that are randomly arranged, not like the 
parallel fibers in intact muscles. Different attempts to affect myotube organization in vitro 
have been tried, such as culturing the cells on micro-patterned glass (Yamamoto, et al., 
2008), in three-dimensional gels or in flow chambers. Co-cultures with adipocytes or 
neurons are other approaches to mimic the in vivo situation more closely. Sophistication of 
the culturing technique will possibly improve the muscle cell system.      
 
Conclusions 
To summarize, human myotubes seem to be a valuable model for the study of glucose and 
lipid metabolism. There are some limitations in differentiation status (fiber type) of the cells 
and energy metabolism that can be improved by proper treatment such as electrical pulse 
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stimulation to mimic exercise.  In vitro vs. in vivo translatability should be further studied 







A. Myotubes were fixed, permeabilized and stained for myosin heavy chain 1 (mouse anti-
slow muscle myosin monoclonal antibody), lipid droplets (bodipy), and nuclei (DAPI). Red 
represents fiber type 1, turquoise represents nuclei, and green represents lipids. B. Human 
muscle biopsy samples were frozen, sectioned and stained for myosin heavy chain 1 (MAB 
1628, Millipore, MA, USA), and lipids (Bodipy 493/503, Invitrogen Molecular Probes). Red 




The myotube to muscle tissue mRNA expression ratio of selected genes.  
Total RNA was isolated, cDNA was synthesized, and real-time qPCR was performed. 
Expression of the selected genes were quantified according to the average of two 
housekeeping genes (GAPDH and 36B4), and the average ratio of expression in myotubes to 
muscle tissue from the same donor is given ± SEM (n=4-18). GAPDH = glyceraldehyde 3-
phosphate dehydrogenase, 36B4 = acidic ribosomal phosphoprotein P0, PGC-1 = peroxisome 
proliferator-activated receptor γ coactivator-1, PPAR = peroxisome proliferator-activated 
receptor, ERR = estrogen-related receptor, GABPA = GA binding protein transcription factor, 
alpha subunit 60 kDa, MCAD = medium-chain acyl-CoA dehydrogenase, CPT1b = carnitine 
palmitoyltransferase 1b, PDK4 = pyruvate dehydrogenase kinase 4, COXIV = cytochrome c 
oxidase IV, CD36 = cluster of differentiation 36/fatty acid translocase, PLIN = perilipin, MYH = 




Suggested strategies to improve oxidative capacity of myotubes and some mechanisms 
involved. Muscle fiber type switch and improved oxidative capacity might be achieved by 
chronic low-frequency stimulation (CLF). Stimulation of AMP-dependent kinase (AMPK) by   
5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) and GW501516, via 
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activation peroxisome proliferator-activated receptor (PPAR) δ, increase fatty acid oxidation. 
Other nuclear receptors, such as the other PPARs and liver X receptor (LXR), may improve 
myotube metabolism, and metformin increases energy uptake. PFI-treatment (palmitate, 
forskolin, ionomycin) improves lipid metabolism and insulin sensitivity. The activator of SIRT 
(silent mating type information regulation 2 homolog) SRT1720 increases lipid oxidation 
probably via PPAR gamma coactivator 1α (PGC-1α). Incubation of myotubes with certain 





Oleic acid oxidation in human myotubes after pretreatment with the PPARδ agonist 
GW501516, the AMPK-activator AICAR and the SIRT-activator SRT1720. Myotubes were 
pretreated with GW501516, AICAR or SRT1720 for 24 h, before 100 µM 14C-labeled oleic acid 
was added and CO2 was trapped for 4 h.  Average amount of CO2 ± SEM is given (n=10). 
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